CN101983670A - Medicament for treating gallstone - Google Patents

Medicament for treating gallstone Download PDF

Info

Publication number
CN101983670A
CN101983670A CN2010105086142A CN201010508614A CN101983670A CN 101983670 A CN101983670 A CN 101983670A CN 2010105086142 A CN2010105086142 A CN 2010105086142A CN 201010508614 A CN201010508614 A CN 201010508614A CN 101983670 A CN101983670 A CN 101983670A
Authority
CN
China
Prior art keywords
grams
gallus domesticus
medicine
treatment
carnis gallus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105086142A
Other languages
Chinese (zh)
Inventor
纪亚洲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105086142A priority Critical patent/CN101983670A/en
Publication of CN101983670A publication Critical patent/CN101983670A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating gallstone. The component proportion of the medicament is as follows: endothelium corneum gigeriae galli 10g, desmodium 10g, pyrrosia leaf 10g, Artemisia capillaries 10g, bitter organe 10g, alisma rhizome 10g, banksia rose 10g and licorice 10g.The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. The medicament has a safe, obvious and complete effect on treating gallstone and is free of any toxic or side effect.

Description

A kind of medicine for the treatment of gallstone disease
Technical field
The present invention relates to a kind of Chinese medicine medicine, a kind of specifically medicine for the treatment of gallstone disease.
Background technology
Gallstone disease is the commonly encountered diseases of biliary system, it is the general name of cholelithiasis, calculus of bile duct, biliary system mainly is to transport in order exercising, to store, concentrate and the effect of excretion of bile, if therefore biliary system itself or bile component make a variation to some extent, then can form solid crystal " cholelithiasis " at any position of biliary system, even cause biliary obstruction, further stimulate the biliary system cancerous lesion of deriving; The curative effect of medication of some treatment gallstone diseases is not thorough, and therapeutic effect is undesirable, and some contains toxic side effect, increases the weight of people's the state of an illness.
Summary of the invention
In order to solve the unfavorable problem of curative effect of medication of treatment gallstone disease, the invention provides a kind of medicine for the treatment of gallstone disease, this invention treatment cholelithiasis is evident in efficacy, takes safe without toxic side effect, cures thoroughly.
Concrete proportioning of the present invention: Carnis Gallus domesticus gold 10 grams, Herba Lysimachiae 10 grams, Folium Pyrrosiae 10 grams, Herba Artemisiae Scopariae 10 grams, Fructus Aurantii 10 grams, Rhizoma Alismatis 10 grams, the Radix Aucklandiae 10 grams, Radix Glycyrrhizae 10 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
Pharmacology of the present invention is: the Carnis Gallus domesticus gold: removing food stagnancy stagnates, strengthening the spleen and stomach; Herba Lysimachiae: heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, dampness removing jaundice eliminating; Folium Pyrrosiae: relieving stranguria by diuresis, lung heat clearing expels the heat-evil; Herba Artemisiae Scopariae: clearing away heat-damp and promoting diuresis, jaundice eliminating, antihypertensive diuretic; Fructus Aurantii: regulating the flow of QI to ease the stomach, the stagnant relieving distension of row; Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen; It is treating stranguria to expel the heat-evil; The Radix Aucklandiae: promoting the circulation of QI to relieve pain; Intestinal stasis relieving in the accent; Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Preparation method of the present invention is: the Carnis Gallus domesticus gold is gone into pot spray vinegar fry dried, the Carnis Gallus domesticus gold is 10: 1 with the amount ratio of vinegar, and the Carnis Gallus domesticus gold after concocting is mixed into sieve with Herba Lysimachiae, Folium Pyrrosiae, Herba Artemisiae Scopariae, the Radix Aucklandiae, Fructus Aurantii, Rhizoma Alismatis, Radix Glycyrrhizae, and the clear water sieve dashes, pull oven dry out, pulverize, machine is made ball and is got final product.
Instructions of taking: one day twice, each 5-6 gram, one month is a course of treatment.
The invention has the beneficial effects as follows: the Drug therapy cholelithiasis effect of this treatment gallstone disease is remarkable, takes safety and has no side effect, and cures thoroughly.
Specific embodiment
Through over 2 years, to the clinical practice of 100 routine calculuss, obtained curative effect preferably, its cure rate reaches more than 95%, and total effective rate reaches 98%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to cholelithiasis patient's clinical manifestation and pathological characters branch, and sex, age do not limit, more than the course of disease 1 week~1 year; Various other of stopping using before the treatment treated the medicine and the therapeutic modality of gallstone diseases.
4. compound method: the Carnis Gallus domesticus gold is gone into pot spray vinegar fry and do, the Carnis Gallus domesticus gold is 10: 1 with the amount ratio of vinegar, and the Carnis Gallus domesticus gold after concocting is mixed into sieve with Herba Lysimachiae, Folium Pyrrosiae, Herba Artemisiae Scopariae, the Radix Aucklandiae, Fructus Aurantii, Rhizoma Alismatis, Radix Glycyrrhizae, and the clear water sieve dashes, pull oven dry out, pulverize, machine is made ball and is got final product.
5. administrated method: one day twice, each 5-6 gram, one month is a course of treatment.
6. efficacy evaluation:
1. recovery from illness: the cholelithiasis symptom disappears.
2. remarkable: the cholelithiasis symptom obviously reduces.
3. effective: curing does not afterwards have recurrence more than 1 year.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat patient's 100 examples altogether, male's 40 examples (40%) wherein, women's 60 examples (60%).
2. age group: 20~25 years old 25 example, 26~30 years old 25 example, 31~40 years old 25 example, 41~55 years old 25 example.
3. prepare the dose scheme for first kind: Carnis Gallus domesticus golden 10 restrains, Herba Lysimachiae 10 restrains, Folium Pyrrosiae 10 restrains, Herba Artemisiae Scopariae 10 restrains, Fructus Aurantii 10 restrains, Rhizoma Alismatis 10 restrains, the Radix Aucklandiae 10 restrains, Radix Glycyrrhizae 10 restrains.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 7 2 1
Moderate patient's 35 examples 30 2 2 1
Severe patient 15 examples 12 1 1 1
The scheme of second kind of preparation dose: Carnis Gallus domesticus gold 11 grams, Herba Lysimachiae 11 grams, Folium Pyrrosiae 11 grams, Herba Artemisiae Scopariae 11 grams, Fructus Aurantii 11 grams, Rhizoma Alismatis 11 grams, the Radix Aucklandiae 11 grams, Radix Glycyrrhizae 11 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 45 examples 35 8 1 1
Moderate patient's 40 examples 35 3 1 1
Severe patient 15 examples 10 3 1 1
By Drug therapy gallstone disease of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, in taking the process of medicine of the present invention, cut out other medicine.This invention treatment cholelithiasis is evident in efficacy, takes safe without toxic side effect, cures thoroughly.

Claims (2)

1. medicine for the treatment of gallstone disease, it is characterized in that: concrete proportioning of the present invention is Carnis Gallus domesticus gold 10 grams, Herba Lysimachiae 10 grams, Folium Pyrrosiae 10 grams, Herba Artemisiae Scopariae 10 grams, Fructus Aurantii 10 grams, Rhizoma Alismatis 10 grams, the Radix Aucklandiae 10 grams, Radix Glycyrrhizae 10 grams, the degree of accuracy of this dose ratio be each medicine ± 10%.
2. medicine for the treatment of gallstone disease, it is characterized in that: preparation method of the present invention is fried dried for the Carnis Gallus domesticus gold being gone into pot spray vinegar, the Carnis Gallus domesticus gold is 10: 1 with the amount ratio of vinegar, Carnis Gallus domesticus gold after concocting is mixed into sieve with Herba Lysimachiae, Folium Pyrrosiae, Herba Artemisiae Scopariae, the Radix Aucklandiae, Fructus Aurantii, Rhizoma Alismatis, Radix Glycyrrhizae, the clear water sieve dashes, pull oven dry out, pulverize, machine is made ball and is got final product.
CN2010105086142A 2010-10-12 2010-10-12 Medicament for treating gallstone Pending CN101983670A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105086142A CN101983670A (en) 2010-10-12 2010-10-12 Medicament for treating gallstone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105086142A CN101983670A (en) 2010-10-12 2010-10-12 Medicament for treating gallstone

Publications (1)

Publication Number Publication Date
CN101983670A true CN101983670A (en) 2011-03-09

Family

ID=43640833

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105086142A Pending CN101983670A (en) 2010-10-12 2010-10-12 Medicament for treating gallstone

Country Status (1)

Country Link
CN (1) CN101983670A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169180A (en) * 2015-09-18 2015-12-23 马鞍山德宏堂生物科技有限公司 Traditional Chinese medicine decoction for treating biliary calculi

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105169180A (en) * 2015-09-18 2015-12-23 马鞍山德宏堂生物科技有限公司 Traditional Chinese medicine decoction for treating biliary calculi

Similar Documents

Publication Publication Date Title
CN102784332A (en) Medicine for treating angiitis
CN101983672A (en) Medicament for treating cramp
CN101983682A (en) Medicament for treating female climacteric metancholia
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN101983670A (en) Medicament for treating gallstone
CN101983650A (en) Medicament for treating dermatitis aestivale
CN102228559B (en) Externally applied ointment for treating children eczema
CN102078432A (en) Medicament for treating skin itch
CN104258308A (en) Traditional Chinese medicine preparation for treating cholelithiasis
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101983681A (en) Medicament for treating abnormal leucorrhea
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN105079661A (en) Traditional Chinese medicine composition for treating hemafecia
CN110507766A (en) A kind of Chinese medicine composition for treating epileptics
CN104606642A (en) Gel for treating traumatic injury and preparation method of gel
CN104383211A (en) Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy
CN117942383A (en) Traditional Chinese medicine composition and preparation for treating acute thrombotic external hemorrhoids and preparation method thereof
CN103169899B (en) Drug for treating hydrops articuli
CN101983686A (en) Medicament for treating insomnia
CN101983694A (en) Traditional Chinese medicine for treating cerebral haemorrhage
CN103028104B (en) Traditional Chinese medicine composition for treating abdominal pain
CN101979010A (en) Chinese medicament for treating metrorrhagia
CN101979051A (en) Traditional Chinese medicine for treating chronic gastritis
CN105381188A (en) Traditional Chinese medicine composition for treating chronic hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110309